ACCESS BIO
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · New Jersey, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
65 Clyde Rd Ste A, Somerset, New Jersey,...Phone Number
(732) 873-4040Website
www.accessbio.netRevenue
$73.4 MillionStock Symbol
950130Industry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
2
1
1
1
1
About ACCESS BIO
Access Bio (KOSDAQ: 950130) is dedicated to the prevention and early diagnosis of infectious diseases through research, development, and manufacturing of in vitro rapid diagnostic tests, biosensors, and molecular diagnostic products. The company's in vitro diagnostic test platform includes immunochemical, biochemical, and molecular products. Headquartered in Somerset, New Jersey, Access Bio serves its global customer base from manufacturing sites located in the U.S., Ethiopia, and South Korea. In 2018 the company reported $36.6 million of revenues, largely from sales of its industry-leading malaria RDT products. The company has commercially launched a number of additional diagnostic tests that leverage its industry-leading expertise and manufacturing capacity.Explore more
ACCESS BIO Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ACCESS BIO your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if ACCESS BIO has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once ACCESS BIO has new funding data
Earning: See what the market has to say on ACCESS BIO recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at ACCESS BIO
Check out if ACCESS BIO is spiking on competitors!
Website visits: Recent activity has been detected on your website
ACCESS BIO, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when ACCESS BIO launches new products
Click to see if ACCESS BIO had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to ACCESS BIO
Compare insights from companies similar to ACCESS BIO, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$7M
51-200
Private
$40.8M
2007
MS
Maithreyan SrinivasanTechnology Senior Director, Research & Development
Company Profile Activity
Activity Insights
ACCESS BIO is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ACCESS BIO is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ACCESS BIO.
ACCESS BIO Tech Stack
A closer look at the technologies used by ACCESS BIO
See more technologies
Most Recent Scoops
Project
, according to a mid-level source in logistics, is planning to begin initiatives related to inventory control and management within three months. ACCESS BIO will be increasing funding to support these efforts. The organization is planning to leverage an internally developed enterprise resource planning (ERP) system in this area.
Spending/Investment, Financial Planning, Funding, Enterprise Software, Software, Logistics / Supply Chain, Inventory Management, Enterprise Resource Planning, Finance
Pain Point
, according to a mid-level source in logistics, is experiencing challenges related to last mile delivery software.
Pain Point, Software, Logistics / Supply Chain
Project
, according to a mid-level source in logistics, is planning to begin initiatives related to distribution software within three months. ACCESS BIO will be increasing funding to support these efforts. The organization is planning to leverage an internally developed enterprise resource planning (ERP) system in this area.
Spending/Investment, Financial Planning, Funding, Enterprise Software, Software, Logistics / Supply Chain, Enterprise Resource Planning, Finance
Pain Point
, according to a mid-level source in logistics, is experiencing challenges related to direct store delivery software.
Pain Point, Retail/Store Systems, Software, Logistics / Supply Chain
Pain Point
Pain Point, Software, Capacity Planning, Logistics / Supply Chain, Enterprise Resource Planning
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ACCESS BIO
Sign Up For FreeTo access detailed company insights
Access Bio (KOSDAQ: 950130) is dedicated to the prevention and early diagnosis of infectious diseases through research, development, and manufacturing of in vitro rapid diagnostic tests, biosensors, and molecular diagnostic products. The company's in vitro diagnostic test platform includes immunochemical, biochemical, and molecular products. Headqu... Read More
